Insulin Cost Without Insurance 2026: Real Prices
Insulin Cost Without Insurance 2026: Real Prices
Two people walk into two different pharmacies on the same afternoon with the same prescription for long-acting insulin. One pays $25. The other pays $280. Neither of them has insurance.
That spread is the whole story of insulin pricing in America right now. The drug hasn't changed. What changed is which product you're handed and where you buy it — and almost nobody explains that clearly before you're standing at the counter with your card out.
At a glance
- Insulin cost without insurance in 2026 runs from about $25 a vial for older human insulin to $250–$300 a vial for brand-name analogs at full retail.
- The widely quoted $35 a month figure is a Medicare Part D legal cap — it is not an automatic price for uninsured people.
- Walmart's ReliOn human insulin is roughly $25 a vial; ReliOn NovoLog, an analog, is about $73 a vial.
- Unbranded biosimilars and state-backed products like the Civica insulin glargine that launched January 1, 2026 (around $11 a pen) are now the cheapest analog options.
- For most people with type 2 diabetes, insulin is no longer the expensive part of the prescription bill — the newer drugs alongside it are.
How much does insulin cost without insurance in 2026?
There is no single answer, because "insulin" covers three very different tiers of product at three very different prices.
| Insulin type | Examples | Typical cash price per 10 mL vial | Roughly per month* |
|---|---|---|---|
| Human insulin (older) | Novolin R, Novolin N, Novolin 70/30, ReliOn versions | $25 – $50 | $25 – $75 |
| Unbranded / biosimilar analogs | Insulin lispro, insulin aspart, insulin glargine-yfgn | $25 – $75 | $40 – $110 |
| Brand-name analogs | Lantus, Humalog, NovoLog, Tresiba, Apidra, Toujeo | $190 – $300+ | $250 – $500 |
*Assuming a common dose of roughly 40–60 units a day. Your number depends entirely on your dose, which is covered below.
A 2026 GoodRx analysis found the average price per unit of insulin fell 42%, from $0.33 in 2019 to $0.19 by mid-2024 — the lowest in a decade. Real progress. But averages hide the spread, and plenty of people are still paying the top of that table because nobody told them the bottom of it existed.
Why you keep seeing "$35 insulin" — and who actually gets it
Search insulin pricing and you'll hit the $35 figure within about four seconds. It's worth being precise about what it is.
The Inflation Reduction Act capped insulin cost sharing at $35 per month for Medicare beneficiaries — Part D from January 2023, Part B from July 2023. Deductibles don't apply to it. For 2026, the calculation is the lower of $35 or 25% of the drug's Maximum Fair Price. Every Part D plan has to honor it.
That's a law, and it's a good one. It also only covers people on Medicare.
If you're uninsured, under 65, and paying cash, the $35 cap does nothing for you directly. You can still get to $35 or below — several routes below land there — but it takes a deliberate choice at the pharmacy, not a card in your wallet.
Worth saying plainly: much of the advice online blurs the Medicare cap together with other programs and leaves uninsured readers assuming a low price will simply appear. It won't. You have to ask for it.
Insulin prices by brand in 2026
Here's where specific products land. CanAmerica Plus cash prices below are the listed prices as of August 31, 2026, for a 10 mL vial unless noted.
| Product | Type | US retail (no insurance) | CanAmerica Plus cash price |
|---|---|---|---|
| Lantus (insulin glargine) | Long-acting | $250 – $300 | $218.99 / vial |
| Humalog (insulin lispro) | Rapid-acting | $250 – $300 | $196.99 / vial |
| Apidra (insulin glulisine) | Rapid-acting | $250 – $300 | $191.99 / vial |
| Semglee (insulin glargine-yfgn) | Long-acting biosimilar | $150 – $200 / 5 pens | $111.99 / 5 pens |
| NovoLog (insulin aspart) | Rapid-acting | $250 – $300 | Not currently listed |
| Tresiba (insulin degludec) | Ultra-long-acting | $350 – $500 | Not currently listed |
| Levemir (insulin detemir) | Long-acting | $250 – $350 | Availability varies |
| Novolin R / N / 70-30 | Human insulin | $25 – $50 | Not currently listed |
Semglee is the one to look at twice. It's interchangeable with Lantus, which means a pharmacist can substitute it the way they'd substitute a generic — no new prescription needed in most states. At $111.99 for five pens, it works out to less than half the per-unit cost of brand Lantus.
How to calculate what your insulin actually costs per month
This is the piece almost every pricing article skips, and it's the only way to compare options honestly. Two numbers make it work.
A 10 mL vial of U-100 insulin holds 1,000 units. A box of five 3 mL pens holds 1,500 units.
That's it. Now multiply your daily dose by 30.
| Your daily dose | Units per month | Vials per month | Pen boxes per month |
|---|---|---|---|
| 20 units | 600 | ~0.6 | ~0.4 |
| 40 units | 1,200 | ~1.2 | ~0.8 |
| 60 units | 1,800 | ~1.8 | ~1.2 |
| 100 units | 3,000 | ~3 | ~2 |
Then divide any package price by the units it contains to get your cost per unit — the only number that lets you compare a vial against a pen box against a five-pack.
| Product | Package | Units | Price | Cost per unit |
|---|---|---|---|---|
| ReliOn Novolin R / N (Walmart) | 10 mL vial | 1,000 | ~$25 | $0.025 |
| Civica insulin glargine-yfgn | 3 mL pen | 300 | ~$11 | $0.037 |
| Cost Plus generic insulin glargine | 10 mL vial | 1,000 | ~$40 – $55 | $0.040 – $0.055 |
| ReliOn NovoLog (Walmart) | 10 mL vial | 1,000 | ~$73 | $0.073 |
| Semglee via CanAmerica Plus | 5 pens (15 mL) | 1,500 | $111.99 | $0.075 |
| Humalog via CanAmerica Plus | 10 mL vial | 1,000 | $196.99 | $0.197 |
| Lantus via CanAmerica Plus | 10 mL vial | 1,000 | $218.99 | $0.219 |
| Brand analog, US retail sticker | 10 mL vial | 1,000 | $250 – $300 | $0.250 – $0.300 |
Someone taking 50 units a day needs about 1,500 units a month. At $0.025 a unit that's roughly $38. At $0.25 a unit it's $375. Same insulin requirement, ten times the bill.
Two practical notes on that math. Insulin in use typically has to be discarded after 28 days regardless of how much is left, so partial vials do get wasted — build in a little slack. And most prescriptions are written for a 30- or 90-day supply based on your dose, so ask your prescriber to write the quantity that matches your actual usage rather than a default.
The cheapest insulin without insurance — and the trade-offs
Walmart ReliOn human insulin, around $25 a vial
Walmart sells ReliOn-branded human insulin — Regular (R), NPH (N), and the 70/30 mix — for roughly $25 a vial. In most states, human insulin does not require a prescription, though you should never start it without your prescriber's input. ReliOn NovoLog, a genuine rapid-acting analog, runs about $73 a vial and about $86 for a pack of FlexPens.
This is the cheapest legitimate insulin in the country. It is also not a like-for-like swap, which the next section covers.
Unbranded biosimilars and interchangeable products
Unbranded insulin lispro (chemically the same as Humalog) and unbranded insulin aspart (same as NovoLog) sell for roughly $25 to $75 a vial at many pharmacies. They are the identical molecule in different packaging. Ask the pharmacist directly: "Is there an unbranded or interchangeable version of this insulin?" Many won't volunteer it.
Insulin glargine-yfgn — sold as Semglee and unbranded — is interchangeable with Lantus and usually pharmacist-substitutable without a new prescription.
Civica and state-backed insulin
Civica, a nonprofit manufacturer, released its first insulin product — insulin glargine-yfgn, a long-acting biosimilar interchangeable with Lantus — on January 1, 2026. It's priced around $11 per pen or $55 for a five-pack, independent of insurance status. Availability is expanding rather than universal, so call ahead.
Cost Plus Drugs
Mark Cuban's Cost Plus Drugs lists generic insulin glargine vials in the $40 to $55 range. Transparent pricing, mail order, prescription required.
Savings tip: Before you fill anything, call three pharmacies with one question: "What's your cash price for this insulin, and do you have an unbranded or interchangeable version?" Cash prices for the same product routinely differ by $100 or more between two stores in the same zip code, and the unbranded version is often sitting on the shelf behind the branded one.
What switching to $25 insulin actually costs you
Every article listing cheap insulin should say this part out loud, and most don't.
Human insulin (Novolin R and N) is not a cheaper version of the analog you're on. It's an older drug that behaves differently in your body. Regular human insulin has to be injected roughly 30 minutes before eating rather than at the meal, and it stays active longer afterward — which means a delayed meal can drop your blood sugar hard. NPH peaks several hours after injection instead of staying flat, so it demands more rigid meal timing and carries a higher risk of overnight hypoglycemia than a modern basal insulin.
Research consistently shows people can achieve reasonable control on human insulin. It also shows more hypoglycemia and less flexibility. For someone with type 2 diabetes on a stable schedule, that trade may be entirely manageable. For someone with type 1, on a pump, working shifts, or with hypoglycemia unawareness, it can be genuinely unsafe.
The dosing is not interchangeable either. Switching insulin types is a change your prescriber has to make — not something to do at the pharmacy counter because the price was better.
If cost is the reason you're considering it, say exactly that to your doctor. "I can't afford $280 a month, what are my options" is a conversation most prescribers have several times a week, and there is often a cheaper analog they can switch you to without stepping back a generation.
Insulin isn't the whole diabetes bill
Here's the part that surprises people, and it reframes the question.
Insulin got dramatically cheaper over the last five years. The rest of the diabetes cabinet didn't. If you have type 2 diabetes in 2026, your insulin might be $40 a month while the tablet next to it is $600.
| Medication | US retail per month | CanAmerica Plus cash price |
|---|---|---|
| Jardiance (empagliflozin) | $600 – $830 | $219.99 / 90 tabs |
| Ozempic (semaglutide) | $900 – $1,000 | $499.99 / 2 pens |
| Metformin | $15 – $40 | $51.99 / 100 tabs |
Then there are the supplies, which no pricing guide should leave out: pen needles and syringes run $20 to $50 a month, test strips $30 to $100, and a continuous glucose monitor $200 to $400 a month without coverage. An insulin pump can run past $1,000 upfront.
Add it up honestly and the picture flips. Cutting your insulin from $250 to $40 saves $2,500 a year, which matters enormously. But if you're also paying full retail for a newer oral or injectable, that single line may be costing more than everything else combined. Our guides to Jardiance costs and Ozempic costs without insurance go through those numbers in detail.
This is where a cash-pay network earns its keep, and it's worth being straight about where it doesn't. For basic human insulin, Walmart at $25 a vial is hard to beat and you should just go there. For brand-name analogs and the newer diabetes drugs, cross-border cash pricing is often a fraction of US retail. Use whichever route is cheaper for each prescription — there's no rule saying they all have to come from one place.
If you're about to run out of insulin
Do not ration. Skipping or stretching doses risks diabetic ketoacidosis, which is a medical emergency.
Most states have emergency refill laws allowing a pharmacist to dispense an emergency supply of insulin without a current prescription — commonly a 30-day supply, though it varies by state. Ask the pharmacist directly for an emergency refill and say it's insulin.
If you're within hours of running out, an urgent care clinic or emergency department can bridge you. Walmart ReliOn human insulin, available without a prescription in most states, is also a legitimate stopgap — but tell your doctor immediately afterward, because the dosing differs from analog insulin.
The bottom line
Insulin cost without insurance in 2026 depends almost entirely on which product you're handed. Older human insulin is about $25 a vial. Unbranded and biosimilar analogs run $25 to $75. Brand-name analogs at full retail still hit $250 to $300, and nothing forces you to pay that.
Work out your cost per unit, call a few pharmacies, ask specifically for the unbranded or interchangeable version, and talk to your prescriber before switching insulin types — the cheapest option on the shelf is not always the right one for your body. Then check the rest of your prescriptions, because in 2026 that's usually where the real money is going. You can compare cash prices on CanAmerica Plus against what you're paying now.
Frequently asked questions
How much does a month supply of insulin cost without insurance?
Between roughly $25 and $500, depending on the product and your dose. Someone taking 50 units a day of human insulin pays about $38 a month; the same dose of a brand-name analog at retail sticker price is closer to $375. Work out your units per month, then divide package prices by units to compare.
How much is insulin without insurance at Walmart?
ReliOn human insulin (Novolin R, N, and 70/30) is about $25 a vial. ReliOn NovoLog, a rapid-acting analog, runs about $73 a vial or $86 for a pack of FlexPens. Human insulin doesn't require a prescription in most states, but talk to your doctor before switching to it.
Who qualifies for $35 insulin?
The $35 monthly cap written into the Inflation Reduction Act applies to people with Medicare Part D or Part B coverage. It is not an automatic price for uninsured people. Uninsured patients can still reach $35 or less through human insulin, unbranded biosimilars, or state-backed products like Civica's insulin glargine — but you have to ask for those specifically.
What's the cheapest insulin without insurance?
Walmart's ReliOn human insulin at roughly $25 a vial is the cheapest, but it's an older drug that requires stricter meal timing and carries more hypoglycemia risk. Among modern analogs, Civica's insulin glargine (~$11 a pen) and unbranded insulin lispro or aspart ($25–$75 a vial) are the lowest-cost options.
Can I switch to cheaper insulin on my own?
No. Different insulin types have different onset, peak, and duration, and the doses are not interchangeable. Switching without a prescriber's guidance risks dangerous highs and lows. Bring the price to your doctor and ask what's clinically appropriate — there's often a cheaper option within the same category.
This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment. Pricing information is current as of the publication date but may change. Verify pricing directly before making purchasing decisions.